SKBA Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $629K | Buy |
1,198
+221
| +23% | +$116K | 0.09% | 67 |
|
|
2025
Q1 | $620K | Buy |
977
+237
| +32% | +$150K | 0.09% | 66 |
|
|
2024
Q4 | $527K | Hold |
740
| – | – | 0.08% | 64 |
|
|
2024
Q3 | $778K | Hold |
740
| – | – | 0.12% | 60 |
|
|
2024
Q2 | $778K | Sell |
740
-15
| -2% | -$15.8K | 0.12% | 61 |
|
|
2024
Q1 | $727K | Buy |
755
+5
| +0.7% | +$4.81K | 0.11% | 59 |
|
|
2023
Q4 | $659K | Sell |
750
-45
| -6% | -$39.5K | 0.11% | 58 |
|
|
2023
Q3 | $654K | Hold |
795
| – | – | 0.12% | 57 |
|
|
2023
Q2 | $571K | Hold |
795
| – | – | 0.1% | 59 |
|
|
2023
Q1 | $653K | Sell |
795
-50
| -6% | -$41.1K | 0.12% | 57 |
|
|
2022
Q4 | $610K | Hold |
845
| – | – | 0.11% | 56 |
|
|
2022
Q3 | $582K | Hold |
845
| – | – | 0.12% | 54 |
|
|
2022
Q2 | $500K | Hold |
845
| – | – | 0.1% | 56 |
|
|
2022
Q1 | $590K | Hold |
845
| – | – | 0.11% | 55 |
|
|
2021
Q4 | $534K | Hold |
845
| – | – | 0.1% | 58 |
|
|
2021
Q3 | $511K | Hold |
845
| – | – | 0.1% | 59 |
|
|
2021
Q2 | $472K | Buy |
845
+100
| +13% | +$55.9K | 0.09% | 61 |
|
|
2021
Q1 | $352K | Buy |
745
+145
| +24% | +$68.5K | 0.06% | 66 |
|
|
2020
Q4 | $290K | Buy |
600
+10
| +2% | +$4.83K | 0.05% | 66 |
|
|
2020
Q3 | $330K | Sell |
590
-40
| -6% | -$22.4K | 0.07% | 62 |
|
|
2020
Q2 | $393K | Sell |
630
-70
| -10% | -$43.7K | 0.08% | 56 |
|
|
2020
Q1 | $342K | Hold |
700
| – | – | 0.08% | 56 |
|
|
2019
Q4 | $263K | Buy |
+700
| New | +$263K | 0.04% | 69 |
|